Joe Allen, Executive Director of The Bayh-Dole Coalition, was at the forefront of the Bayh-Dole Act back in December 1980
Invest
Innovate
Cure
Incubate advocates for the patient, corporate, and investment communities by educating policymakers on the role of venture capital in bringing promising, innovative treatments to patients in need.
What We Do
-
Foster innovation
Help ensure a level global playing field for investment and promote policies that empower life science innovators to build and grow in the United States.
-
Safeguard advancements
Strengthen and protect U.S. intellectual property provisions by promoting patent and regulatory systems that encourage life sciences innovation.
-
Amplify the results
Spotlight the venture capital-driven breakthroughs that are transforming medicine for patients and health professionals around the globe.
Latest News
-
-
From Idea to Prescription: Bringing a Drug to Market
Bringing a new drug to market is a complex and lengthy process that involves multiple phases of research, development, testing, and regulatory hurdles. Venture capital plays a critical role in each phase.
-
Incubate Joins Bipartisan Chorus: March-In Proposal Is Bad Policy
Read Incubate’s blog on the recently announced March-In proposal.
-
Incubate Submits Letter on HELP Committee Hearing
Incubate is an international coalition of life science venture capitalists committed to educating
policymakers on the role of venture capital in bringing promising, innovative treatments to patients in
need.
making medicine
Stories from the Early-Stage Life Sciences Ecosystem
Listen to industry experts delve into the process behind scientific breakthroughs (and how many of them almost never happened), where the life science ecosystem is taking us next, and most importantly, what it means for patients.
Events
Global Health Idea Lab Virtual Summit
11.04.2022
Join our Virtual Summit as we embrace and nurture diverse talents, creativity, curiosity, and collaboration. We dive deep into the…